Nothing
#' Ankylosing Spondylitis.
#'
#' Data set containing historical information for placebo for a phase
#' II trial of ankylosing spondylitis patients. The primary efficacy
#' endpoint was the percentage of patients with a 20% response
#' according to the Assessment of SpondyloArthritis international
#' Society criteria for improvement (ASAS20) at week 6.
#'
#' @format A data frame with 8 rows and 3 variables:
#' \describe{
#' \item{study}{study}
#' \item{n}{study size}
#' \item{r}{number of events}
#' }
#' @references Baeten D. et. al, \emph{The Lancet}, 2013, (382), 9906, p 1705
#'
#' @template example-start
#' @examples
#' set.seed(34563)
#' map_AS <- gMAP(cbind(r, n-r) ~ 1 | study,
#' family=binomial,
#' data=AS,
#' tau.dist="HalfNormal", tau.prior=1,
#' beta.prior=2)
#' @template example-stop
"AS"
Any scripts or data that you put into this service are public.
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.